Balancing toxicity and efficacy: learning from trials and treatment using antiresorptive therapy in prostate cancer
- PMID: 23948437
- DOI: 10.1016/j.eururo.2013.07.026
Balancing toxicity and efficacy: learning from trials and treatment using antiresorptive therapy in prostate cancer
Comment on
-
Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer.Eur Urol. 2014 Feb;65(2):278-86. doi: 10.1016/j.eururo.2013.05.015. Epub 2013 May 13. Eur Urol. 2014. PMID: 23706567 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical